News and features

A type of smart MRI scan used in people with heart disease could help assess whether children’s cancers are especially aggressive and spot early signs that targeted treatments are working, a new study suggests.

The ICR has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer.

A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma – a common childhood tumour with a low survival rate.

A major phase III trial of capivasertib, a cancer drug discovered following collaborative work between The Institute of Cancer Research, London, and partners, has begun in breast cancer.

A new precision medicine targeting cancer’s ability to repair its DNA has shown promising results in the first clinical trial of the drug class.

A personalised cancer vaccine, used in combination with an immunotherapy drug, triggers a response from the immune system that is specific to the cancer and shows some clinical benefit, according to the results of an early clinical trial presented at the virtual AACR conference.

Cancers are often heavily reliant on breaking down fats for their growth and spread, and could be treated by a highly innovative combination of new drugs and dietary changes, a major new study concludes.

ICR researchers are returning to their labs this week as we start to ramp up our pioneering cancer research following the disruption caused by the pandemic.

A company formed as a spinout from Cancer Research UK-funded science at The Institute of Cancer Research, London, has been publicly launched – revealing $32.5m in funding and a library of innovative anti-cancer compounds.

The parents of Isabella Ortiz, who died from a brain tumour, have highlighted the need for rare tissue donation, to help other children facing the same condition.

As an organisation that believes passionately in equality, we want to express our solidarity with our Black, Asian and minority ethnic staff following the death of George Floyd.

Scientists have shown that therapies which combine heat and radiation have a different effect on lab-grown mini tumours than they do on lab-grown cancer cells grown in a more traditional way in a two-dimensional layer.